Chronic pain intervention using pulsed shortwave therapy: the relationship between pain demographics and central sensitization inventory

Pain Manag. 2019 May;9(3):283-296. doi: 10.2217/pmt-2018-0032. Epub 2019 May 29.

Abstract

Aim: The central sensitization inventory (CSI) is a validated, patient-reported questionnaire that quantifies symptoms of hypersensitivity disorders such as chronic pain, for which central sensitization (CS) may be the etiology. Objective: To investigate the analgesic effectiveness of ActiPatch and analyze the relationship between baseline CSI scores and demographics of chronic pain sufferers. Methods: Upon completing a 7-day ActiPatch trial, baseline CSI scores along with other assessment measures were obtained via e-mail from 174 chronic pain sufferers. Conclusion: CSI scores were positively correlated with gender (higher for women), baseline visual analog scale scores and pain duration. ActiPatch was found to be effective in reducing baseline pain for all subjects by an average of 4.3 visual analog scale points.

Keywords: PSWT; central sensitization; central sensitization inventory; chronic pain; pain duration; pain relief; pulsed shortwave therapy.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Central Nervous System Sensitization / physiology*
  • Child
  • Chronic Pain / diagnosis*
  • Chronic Pain / therapy*
  • Demography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Registries
  • Sex Factors
  • Short-Wave Therapy / methods*
  • Surveys and Questionnaires*
  • Time Factors
  • Treatment Outcome
  • United Kingdom
  • Young Adult